RxDoctor Payments Data

Mahmoud Goodarzi, MD

Anatomic Pathology & Clinical Pathology · Needham, MANPI 1447425954

Payments from drug & device makers

$54in general payments, 2019–2025

Across 2 payments — averaging $27.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stemline Therapeutics Inc.$28
  • GSK$26

What the payments were for

  • Food & beverage$54100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stemline Therapeutics Inc.1$28
GSK1$26

How this compares

$54 in reported general payments places this provider in the 35th percentile of 196 anatomic pathology & clinical pathology providers in Massachusetts.

See all anatomic pathology & clinical pathology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$1,525,272
Medicare patients
3,414
Services billed
26,066

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Needham

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →